Bio-Rad Share Price

Bio-Rad Share Price

NYSE: BIO.B | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Bio-Rad Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
$289.23 - $298.50
Volume
N/A
Average Traded
N/A

Bio-Rad Share Price Chart

$0.00$0.00
L
Show Current Price
H

Bio-Rad Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
10.25
Dividend Yield
0.00%
EPS (TTM)
$38.04
Revenue (TTM)
$2.58T
Return On Equity (TTM)
13.45%
Profit Margin
29.42%
Debt to Equity
0.16
Quarterly Earnings Growth YoY
-36.31%

Bio-Rad Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$693.20$592.10$651.00$656.40
Net Profit$720.00-$527.10$371.40$458.60
Net Profit Margin103.87%-89.02%57.05%69.87%
Income ChangeN/A-173.21%170.46%23.48%

Bio-Rad Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2802.20$2671.20$2566.50$2583.20
Net Profit-$3627.50-$637.30-$1844.20$759.90
Net Profit Margin-129.45%-23.86%-71.86%29.42%
Income ChangeN/A82.43%-189.38%141.20%

Bio-Rad Balance Sheet

All figures in USD Billion

Particulars2025202420232022
Non Current Assets7.676.339.2510.34
Current Assets2.913.033.053.16
Total Assets10.589.3612.313.5
Non Current Liabilities2.612.333.043.32
Current Liabilities0.520.470.520.57
Total Liabilities3.122.793.563.89
Shareholders' Equity7.456.578.749.62

Bio-Rad Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating532.2455.2374.9194.4
Investing-189.7-160.220.2-1,207.6
Financing-283.2-218.8-425.6973.6

About Bio-Rad

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Bio-Rad Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Jul 2026
$298.50
$298.50
+3.21%
Jun 2026
$289.23
$289.23
+15.65%
Jul 2025
$250.08
$250.08
+0.00%
Jun 2025
$250.08
$250.08
+0.00%
May 2025
$234.41
$250.08
+6.68%
Apr 2025
$241.99
$234.41
-3.13%
Mar 2025
$456.10
$241.99
-46.94%
Feb 2025
$456.10
$456.10
+0.00%
Jan 2025
$456.10
$456.10
+0.00%
Dec 2024
$456.10
$456.10
+0.00%
Nov 2024
$456.10
$456.10
+0.00%
Oct 2024
$456.10
$456.10
+0.00%

Bio-Rad Share Price FAQs